tirzepatide bmi (ZEPBOUND) Approved for Chronic Weight Management in Adults with Obesity β¨ The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or π’ ACP Obesity Guidelines 2026
Pay in 4 interest-free payments of $6.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 23 - Aug 28






























